Shandong Xinhua Pharma Renews Trademark Licence with Hualu; Shares Down 3%

MT Newswires Live

2025/10/27

Shandong Xinhua Pharmaceutical (HKG:0719, SHE:000756) said it has renewed its trademark licence agreement with Shandong Xinhua Pharmaceutical Branch of Hualu for another three years from January 2026 to December 2028, according to an Oct. 24 Hong Kong bourse filing.

Hong Kong-listed shares of the firm were down over 3% in Monday morning trade.

Under the new agreement, the company will pay an annual licence fee of about 14.4 million yuan, up from 10 million yuan under the previous arrangement.

The agreement allows the company to continue using the "Xinhua" trademark for its pharmaceutical and chemical products in and outside mainland China, it said.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2578774660"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2578774660\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2578774660?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-27 11:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2578774660","market":"hk","top_or_hot":-1,"title":"Shandong Xinhua Pharma Renews Trademark Licence with Hualu; Shares Down 3%","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/SXPHF\">Shandong Xinhua</a> Pharmaceutical (HKG:0719, SHE:000756) said it has renewed its trademark licence agreement with <a href=\"https://laohu8.com/S/000756\">Shandong Xinhua</a> Pharmaceutical Branch of Hualu for another three years from January 2026 to December 2028, according to an Oct. 24 Hong Kong bourse filing.</p><p>Hong Kong-listed shares of the firm were down over 3% in Monday morning trade.</p><p>Under the new agreement, the company will pay an annual licence fee of about 14.4 million yuan, up from 10 million yuan under the previous arrangement.</p><p>The agreement allows the company to continue using the \"Xinhua\" trademark for its pharmaceutical and chemical products in and outside mainland China, it said.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shandong Xinhua Pharma Renews Trademark Licence with Hualu; Shares Down 3%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShandong Xinhua Pharma Renews Trademark Licence with Hualu; Shares Down 3%\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-10-27 11:19</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/SXPHF\">Shandong Xinhua</a> Pharmaceutical (HKG:0719, SHE:000756) said it has renewed its trademark licence agreement with <a href=\"https://laohu8.com/S/000756\">Shandong Xinhua</a> Pharmaceutical Branch of Hualu for another three years from January 2026 to December 2028, according to an Oct. 24 Hong Kong bourse filing.</p><p>Hong Kong-listed shares of the firm were down over 3% in Monday morning trade.</p><p>Under the new agreement, the company will pay an annual licence fee of about 14.4 million yuan, up from 10 million yuan under the previous arrangement.</p><p>The agreement allows the company to continue using the \"Xinhua\" trademark for its pharmaceutical and chemical products in and outside mainland China, it said.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1515","symbol_name":"抗疫概念","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2578774660","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2578774660","pubTimestamp":1761535144,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Shandong Xinhua Pharmaceutical  said it has renewed its trademark licence agreement with Shandong Xinhua Pharmaceutical Branch of Hualu for another three years from January 2026 to December 2028, according to an Oct. 24 Hong Kong bourse filing.Hong Kong-listed shares of the firm were down over 3% in Monday morning trade.Under the new agreement, the company will pay an annual licence fee of about 14.4 million yuan, up from 10 million yuan under the previous arrangement.The agreement allows the company to continue using the \"Xinhua\" trademark for its pharmaceutical and chemical products in and outside mainland China, it said.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1515":"抗疫概念","BK1191":"制药","000756":"新华制药","00719":"山东新华制药股份","BK0164":"国企混改","BK0239":"医药制造"},"translate_title":"山东新华制药与华录续签商标许可；股价下跌3%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00719":0.9,"000756":0.9},"content_text":"Shandong Xinhua Pharmaceutical (HKG:0719, SHE:000756) said it has renewed its trademark licence agreement with Shandong Xinhua Pharmaceutical Branch of Hualu for another three years from January 2026 to December 2028, according to an Oct. 24 Hong Kong bourse filing.Hong Kong-listed shares of the firm were down over 3% in Monday morning trade.Under the new agreement, the company will pay an annual licence fee of about 14.4 million yuan, up from 10 million yuan under the previous arrangement.The agreement allows the company to continue using the \"Xinhua\" trademark for its pharmaceutical and chemical products in and outside mainland China, it said.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}